In honor of World Blindness Awareness Month, "GMA" is spotlighting a breakthrough gene therapy that's helping some blind ...
The U.S. Food and Drug Administration has placed a clinical hold on Intellia Therapeutics' two late-stage trials testing an ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
In 1962, a pediatric neurology resident at Columbia's Neurological Institute and his colleagues in the College of Physicians ...
Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...
An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...
Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons ...
The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...
BioMarin no longer expects to hit its $4 billion revenue target by 2027, citing various market factors such as impending ...
As of May 2025, RGX-202 displayed favourable safety, with no serious adverse events (SAEs) and adverse events of special ...
FDA moves to speed biosimilar approvals by eliminating comparative studies, aiming to lower drug costs and increase ...
ABC 11 Raleigh, NC on MSN
Duke Eye Center pioneers new gene therapy for rare eye disease
Duke Eye Center has become the first academic medical center in the country to implant a new cell-based gene therapy for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback